Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells

Journal of Cellular Physiology

Volumn 204, Issue 3, 2005, Pages 881-888

  Kim, Hyo Jung ^a   Vosseler, Claudia A ^a   Weber, Peter C ^a   Erl, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DNA; DOCOSAHEXAENOIC ACID; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN; WESTERN BLOTTING;

APOPTOSIS; ARACHIDONIC ACID; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; DNA; DNA FRAGMENTATION; DOCOSAHEXAENOIC ACIDS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOSERINE; PHOSPHOTYROSINE; SUPEROXIDES; TUMOR SUPPRESSOR PROTEIN P53; UMBILICAL CORD;

EID: 23244465860     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20351     Document Type: Article

References (46)

1. Arita K, Kobuchi H, Utsumi T, Takehara Y, Akiyama J, Horton AA, Utsumi K. 2001. Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem Pharmacol 62:821-828.
2. Artwohl M, Roden M, Waldhäusl W, Freudenthaler A, Baumgartner-Parzer SM. 2004. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146-148.
3. Bottger A, Bottger V, Sparks A, Liu WL, Howard SF, Lane DP. 1997. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol 7:860-869.
4. Cai J, Jones DP. 1998. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273:11401-11404.
5. Calder PC. 2003. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 38:343-352.
6. Calviello G, Palozza P, Piccioni E, Maggiano N, Frattucci A, Franceschelli P, Bartoli GM. 1998. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: Effects on proliferation and apoptosis. Int J Cancer 75:699-705.
7. Chamras H, Ardashian A, Heber D, Glaspy JA. 2002. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13:711-716.
8. Chen ZY, Istfan NW. 2000. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 63:301-308.
9. Connolly JM, Gilhooly EM, Rose DP. 1999. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 35:44-49.
10. Danesch U, Weber PC, Sellmayer A. 1996. Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in Swiss 3T3 fibroblasts. J Cell Physiol 168:618-624.
11. Diep QN, Touyz RM, Schiffrin EL. 2000. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-α ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36:851-855.
12. Dimmeler S, Haendeler J, Galle J, Zeiher AM. 1997. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95:1760-1763.
13. Erl W, Weber C, Hansson GK. 2000. Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+). Am J Physiol Cell Physiol 278:C1116-C1125.
14. Erl W, Weber C, Zernecke A, Neuzil J, Vosseler CA, Kim HJ, Weber PC. 2004. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma. Eur J Immunol 34:241-250.
15. Felmeden DC, Blann AD, Lip GY. 2003. Angiogenesis: Basic pathophysiology and implications for disease. Eur Heart J 24:586-603.
16. Fleury C, Mignotte B, Vayssiere JL. 2002. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84:131-141.
17. Germain E, Lavandier F, Chajes V, Schubnel V, Bonnet P, Lhuillery C, Bougnoux P. 1999. Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity. Lipids 34:8203.
18. Gottlieb TM, Oren M. 1998. p53 and apoptosis. Semin Cancer Biol 8:359-368.
19. Grossman JD, Grossman W. 2002. Angiogenesis. Rev Cardiovasc Med 3:138-144.
20. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM. 2003. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol 63:925-932.
21. Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, Hussain SN. 2003. Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB J 17:1523-1525.
22. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. 1999. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 59:2596-2601.
23. Kachhap SK, Dange PP, Santani RH, Sawant SS, Ghosh SN. 2001. Effect of omega-3 fatty acid (docosahexanoic acid) on BRCAl gene expression and growth in MCF-7 cell line. Cancer Biother Radiopharm 16:257-263.
24. Kurosawa A, Miwa H, Hirose M, Tsune I, Nagahara A, Sato N. 2002. Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells. J Med Microbiol 51:385-391.
25. Larsson SC, Kumlin M, Ingelman-Sundberg M, WoIk A. 2004. Dietary long-chain n-3 fattv acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 79:935-945.
26. Leaf A, Weber PC. 1988. Cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549-557.
27. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. 2002. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 62:625-631.
28. Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC. 1983. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 67:504-511.
29. Lu H, Fisher RP, Bailey P, Levine AJ. 1997. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol Cell Biol 17:5923-5934.
30. Maziere C, Conte MA, Degonville J, Ali D, Maziere JC. 1999. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 265:116-122.
31. Merendino N, Molinari R, Loppi B, Pessina G, D'Aquino M, Tomassi G, Velottia F. 2003. Induction of apoptosis in human pancreatic cancer cells by docosahexaenoic acid. Ann NY Acad Sci 1010:361-364.
32. Michiels C. 2003. Endothelial cell functions. J Cell Physiol 196:430-443.
33. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. 1999. Angiogenesis inhibitors endostatin or TNP-470 reduce intimai neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:1726-1732.
34. Munoz-Chapuli R, Quesada AR, Angel Medina M. 2004. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61:2224-2243.
35. Pakala R, Pakala R, Benedict C. 1999. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation. Lipids 34:915-920.
36. Prives C, Hall PA. 1999. The p53 pathway. J Pathol 187:112-126.
37. Rose DP, Connolly JM. 1999a. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 15:1011-1015.
38. Rose DP, Connolly JM. 1999b. Omega-3 fattv acids as cancer chemopreventive agents. Pharmacol Ther 83:217-244.
39. Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
40. Siess W, Roth P, Scherer B, Kurzmann I, Bohlig B, Weber PC. 1980. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1:441-444.
41. Sperandio S, Poksay K, De Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE. 2004. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 11:1066-1075.
42. Takahashi M, Okazaki H, Ogata Y, Takeuchi K, Ikeda U, Shimada K. 2002. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 161:387-394.
43. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y. 1999. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18:3205-3212.
44. Wada T, Penninger JM. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838-2849.
45. 1 cyclin-dependent kinases. Nature 376:88-91.
46. Yilmaz A, Kliche S, Mayr-Beyrle U, Fellbrich G, Waltenberger J. 2003. p38 MAP Kinase inhibition is critically involved in VEGFR-2-mediated endothelial cell survival. Biochem Biophys Res Commun 306:730-736.